GlassScriptPhysician profile
Kelly Hare
NPI 1821115676
$3,486.02
in general payments reported to CMS, 2019-2025
9 companies · $760 in 2025
The $760 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $589 · 2023: $1,170 · 2024: $967 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,711 · Travel and Lodging: $886 · Education: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,711.41 |
| Travel and Lodging | $886.10 |
| Education | $299.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,224.25 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $995.82 | 2022-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $874.06 | 2022-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $201.58 | 2023-2025 | Lumryz |
| Lilly USA, LLC | $62.42 | 2025 | Zepbound, Mounjaro |
| Zoll Respicardia, INC. | $58.54 | 2023-2025 | Remede System |
| Axsome Therapeutics, INC. | $29.90 | 2025 | Sunosi |
| Vanda Pharmaceuticals INC. | $25.94 | 2023 | Hetlioz |
| Fisher & Paykel Healthcare INC | $13.51 | 2025 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Hare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.